Shasun Pharmaceuticals is currently trading at Rs. 84.30, up by 0.30 points or 0.36% from its previous closing of Rs. 84.00 on the BSE.

The scrip opened at Rs. 86.25 and has touched a high and low of Rs. 87.00 and Rs. 84.00 respectively. So far 52649 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 2 has touched a 52 week high of Rs. 91.50 on 24-Feb-2012 and a 52 week low of Rs. 38.10 on 16-Dec-2011.

Last one week high and low of the scrip stood at Rs. 89.50 and Rs. 83.55 respectively. The current market cap of the company is Rs. 408.02 crore.

The promoters holding in the company stood at 46.73% while Institutions and Non-Institutions held 16.45% and 36.83% respectively. 

Shasun Pharmaceuticals has received its board’s approval for the preferential allotment to Caduceus Mauritius Asia (CAML), a wholly owned subsidiary of OrbiMed Asia Partners. The company will allot 65,78,947 equity shares at Rs 76 per share, aggregating to Rs 50 crore.

OrbiMed is the world’s largest healthcare dedicated investment firm, with about $5 billion in assets under management.

Shasun Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R & D Expertise, regulatory capabilities and multi scale production capacities. It is one of the largest producers of Ibuprofen worldwide.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×